(Q52826904)

8 May 2018

title

Dual expression of CD80 and CD86 produces a tumor vaccine superior to single expression of either molecule. (English)

1 reference

8 May 2018

0 references

Bryon D Johnson

1

1 reference

8 May 2018

Xiaocai Yan

series ordinal

2

1 reference

8 May 2018

Dennis W Schauer

series ordinal

3

1 reference

8 May 2018

Rimas J Orentas

series ordinal

4

1 reference

8 May 2018

publication date

1 March 2003

1 reference

8 May 2018

published in

Cellular Immunology

1 reference

8 May 2018

volume

222

1 reference

8 May 2018

issue

1

1 reference

8 May 2018

page(s)

15-26

1 reference

8 May 2018

describes a project that uses

AGN2a

0 references

cites work

Targeted expression of MYCN causes neuroblastoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Aggressive childhood neuroblastomas do not express caspase-8: an important component of programmed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Quick quantitative analysis of gene dosages associated with prognosis in neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Immune-mediated regression of 'metastatic' neuroblastoma in the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Electrofusion of a weakly immunogenic neuroblastoma with dendritic cells produces a tumor vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Manipulation of costimulatory signals to enhance antitumor T-cell responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Retrovirus-mediated gene transfer of B7-1 and MHC class II converts a poorly immunogenic neuroblastoma into a highly immunogenic one.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Expression and functional analysis of murine B7 delineated by a novel monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Cell surface CD28 levels define four CD4+ T cell subsets: abnormal expression in rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Anti-CD40 antibody induces antitumor and antimetastatic effects: the role of NK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

CD4+ T cell-mediated killing of major histocompatibility complex class II-positive antigen-presenting cells (APC). III. CD4+ cytotoxic T cells induce apoptosis of APC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Recognition of neuroectodermal tumors by melanoma-specific cytotoxic T lymphocytes: evidence for antigen sharing by tumors derived from the neural crest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Mechanism and biological significance of CD4-mediated cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Vaccination with mouse mammary adenocarcinoma cells coexpressing B7-1 (CD80) and B7-2 (CD86) discloses the dominant effect of B7-1 in the induction of antitumor immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Expression of costimulatory molecules CD80 and/or CD86 by a Kaposi's sarcoma tumor cell line induces differential T-cell activation and proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

Interleukin-2 gene transfer into murine neuroblastoma decreases tumorigenicity and enhances systemic immunity causing regression of preestablished retroperitoneal tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Human class II major histocompatibility complex gene transfer into murine neuroblastoma leads to loss of tumorigenicity, immunity against subsequent tumor challenge, and elimination of microscopic preestablished tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900079-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0008-8749(03)00079-0

1 reference

8 May 2018

PubMed ID

12798304

1 reference

8 May 2018